Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • META vs MRNA✓SelectedUSD · MRNAMETA vs MRNA performance historyLatest closeAs of-5.93%11/20
Stock and ETF performance explorer

META vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+312.0%
MRNA return
+786.4%
Excess return
-474.3%
Maximum drawdown
-76.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.9%-2.2%-3.8%-5.8%
7D-12.6%-12.7%+0.1%-12.0%
30D-19.6%-20.7%+1.1%-18.7%
3M+2.8%+46.3%-43.4%+0.6%
6M-7.1%+305.2%-312.4%-18.5%
YTD-14.8%+561.2%-576.1%-28.7%
1Y-4.5%+772.1%-776.6%-22.1%
3Y+66.5%+147.0%-80.4%+45.6%
5Y+64.0%-26.1%+90.1%+52.7%
All+312.0%+786.4%-474.3%+223.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling